Bio: Dr Suzanne Elliott PhD, BappSc, Grad Dip (Drug Dev), ACRP-CCRC, FMPP Suzanne is the Greenslopes Private Hospital’s Gallipoli Medical Research’s (GPH-GMR)-Associate Director of Clinical Trials. In a prior role, she was Operations Manager, Scientific Officer and Deputy CEO of Q-Pharm for over 13 years, a Brisbane-based, Early-Phase clinical trial site company. Starting as a Medical Laboratory Scientist working at many of the east-coast private pathology providers, she completed a molecular oncology PhD at QUT/Mater Hospital. A QIMR Berghofer Post Doctorate followed with experience in cell based vaccines or treatments targeted for EBV/Glandular Fever and post-transplant lymphoproliferative disease. Roles at Vaccine Solutions and the QIMR Berghofer Regulatory Affairs Manager, involved investigator initiated immunotherapy trials in for Hodgkin’s Disease, prostate cancer and melanoma and vaccines in malaria. She has UNSW Drug Development qualifications and Good Clinical Practice accreditation. In the current role, she has responsibility for oversight of the oncology, liver and respiratory studies conducted for the visiting medical officers at the GPH. Suzanne is an Adjunct Professor for QUT, Adjunct Associate Professor at UQ and contributes to various committees for UQ, QUT, and other NHMRC ethics working groups with special interests in early phase adaptive drug design, malaria challenge studies, vaccine studies and research ethics.

With a background as a oncology nurse, Sonia has over 25 years experience in research administration with a strong focus on enabling ethical research conduct within and in collaboration with a large metropolitan health service. Extensive experience in advanced research ethics and integrity, research governance management, and strategic research advisory services. With a continuous improvement mindset and servant leadership style, Sonia’s passion is to foster high quality research outputs by increasing efficiencies and streamlining regulatory approval processes whilst maintaining the highest ethical and integrity standards.

Amy is currently the Global Head of Capabilities, Skills and Learning for Site Management & Monitoring (SM&M) at AstraZeneca. Since joining AZ in 2013, Amy has led the Clinical Research/SM&M team to expand and deliver the evolving R&D portfolio needs across Australia and New Zealand. Amy’s career spans over 25 years in the industry, in both industry and government research-focused roles. This experience includes positions at pharmaceutical, contract research and device organisations, along with the Better Treatment 4 Kids Research Network focused on developing a network of paediatric researchers focused on patient needs. Amy holds a degree in Biomedical Science (majoring in cytopathology) from University of Technology, Sydney and was previously a trained Cytologist. Amy is passionate about continuous learning, coaching and contributing to initiatives which improve efficiency and access to clinical research, including the Medicines Australia Research & Development Taskforce (RDTF), the Australian Clinical Trials Alliance (ACTA) and Transcelerate Biopharma.